Correlation Between NYSE Composite and Corcept Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Corcept Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Corcept Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Corcept Therapeutics Incorporated, you can compare the effects of market volatilities on NYSE Composite and Corcept Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Corcept Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Corcept Therapeutics.
Diversification Opportunities for NYSE Composite and Corcept Therapeutics
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between NYSE and Corcept is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Corcept Therapeutics Incorpora in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corcept Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Corcept Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corcept Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Corcept Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Corcept Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 5.43 times less return on investment than Corcept Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 5.43 times less risky than Corcept Therapeutics. It trades about 0.26 of its potential returns per unit of risk. Corcept Therapeutics Incorporated is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 4,821 in Corcept Therapeutics Incorporated on August 30, 2024 and sell it today you would earn a total of 1,039 from holding Corcept Therapeutics Incorporated or generate 21.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Corcept Therapeutics Incorpora
Performance |
| Timeline |
NYSE Composite and Corcept Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Corcept Therapeutics Incorporated
Pair trading matchups for Corcept Therapeutics
Pair Trading with NYSE Composite and Corcept Therapeutics
The main advantage of trading using opposite NYSE Composite and Corcept Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Corcept Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corcept Therapeutics will offset losses from the drop in Corcept Therapeutics' long position.| NYSE Composite vs. Delek Drilling | NYSE Composite vs. Helmerich and Payne | NYSE Composite vs. Waste Management | NYSE Composite vs. US Global Investors |
| Corcept Therapeutics vs. Ideaya Biosciences | Corcept Therapeutics vs. AnaptysBio | Corcept Therapeutics vs. MeiraGTx Holdings PLC | Corcept Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |